Amirsadri, M., Mousavi, S., & Karimipour, A. (2019). The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran. Daru.
Citação norma ChicagoAmirsadri, Mohammadreza, Sarah Mousavi, and Ali Karimipour. "The Cost-effectiveness and Cost-utility Analysis of the Use of Enoxaparin Compared With Heparin for Venous Thromboembolism Prophylaxis in Medical Inpatients in Iran." Daru 2019.
Citação norma MLAAmirsadri, Mohammadreza, Sarah Mousavi, and Ali Karimipour. "The Cost-effectiveness and Cost-utility Analysis of the Use of Enoxaparin Compared With Heparin for Venous Thromboembolism Prophylaxis in Medical Inpatients in Iran." Daru 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.